Exenatide maintained glyceinic control with associated weight reduction over three years in patients with type 2 diabetes

被引：0
|
作者：
Buse, John
MacConell, Leigh
Stonehouse, Anthony
Guan, Xuesong
Malone, James
Okerson, Ted
Maggs, David
Kim, Dennis
机构：
来源：
DIABETES | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A73 / A74
页数：2
相关论文
共 50 条
  • [1] Exenatide maintained glycemic control with associated weight reduction over 2 years in patients with type 2 diabetes
    Henry, Robert R.
    Ratner, Robert E.
    Stonehouse, Anthony H.
    Guan, Xuesong
    Poon, Terri
    Malone, James K.
    Kim, Dennis D.
    Kendall, David M.
    [J]. DIABETES, 2006, 55 : A116 - A116
  • [2] Exenatide maintained glyeaemic control with associated weight reduction over two years in patients with type 2 diabetes
    Henry, R.
    Ratner, R.
    Stonehouse, A.
    Guan, X.
    Poon, T.
    Malone, J.
    Kim, D.
    Kendall, D.
    [J]. DIABETOLOGIA, 2006, 49 : 473 - 474
  • [3] Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years
    Kristin Taylor
    Kate Gurney
    Jenny Han
    Richard Pencek
    Brandon Walsh
    Michael Trautmann
    [J]. BMC Endocrine Disorders, 11
  • [4] Exenatide once weekly treatment maintained improvements in glycemic control and weight loss over 2 years
    Taylor, Kristin
    Gurney, Kate
    Han, Jenny
    Pencek, Richard
    Walsh, Brandon
    Trautmann, Michael
    [J]. BMC ENDOCRINE DISORDERS, 2011, 11
  • [5] Estimating the Potential Cardiovascular Benefit of A1c Reduction and Weight Loss in Patients with Type 2 Diabetes Treated with Exenatide for at Least Three Years
    Best, Jennie H.
    Herman, William H.
    Wintle, Matthew
    [J]. DIABETES, 2009, 58 : A316 - A316
  • [6] Exenatide Attenuates Pioglitazone Associated Weight Gain in Type 2 Diabetes
    Chavez, Alberto O.
    Guardado-Menndoza, Rodolfo
    Defronzo, Ralph A.
    Tripathy, Devjit
    [J]. DIABETES, 2010, 59 : A203 - A203
  • [7] Exenatide improved markers of hepatic function over 3 years in patients with type 2 diabetes
    Okerson, T.
    Maggs, D.
    Guan, X.
    Bowius, C.
    Holcombe, J.
    Wintle, M.
    Nielsen, L.
    [J]. DIABETOLOGIA, 2007, 50 : S51 - S52
  • [8] Exenatide improved markers of hepatic function over 3 years in patients with type 2 diabetes
    Nielsen, Loretta
    Guan, Xuesong
    Bowlus, Christopher
    Holcombe, John
    Maggs, David
    Wintle, Matthew
    [J]. DIABETES, 2007, 56 : A149 - A150
  • [9] Dynamics of Weight Change and Glycemic Control in Patients with Type 2 Diabetes Treated with Exenatide or Insulin
    Paul, Sanjoy K.
    Best, Jennie H.
    Naughton, Margaret
    Maggs, David
    [J]. DIABETES, 2010, 59 : A181 - A181
  • [10] Metabolic control and weight loss in patients with obesity and type 2 diabetes mellitus, treated with exenatide
    Pujante Alarcon, Pedro
    Hellin Gil, Maria Dolores
    Miguel Roman, Luis
    Ferrer Gomez, Mercedes
    Garcia Zafra, Maria Victoria
    Tebar Masso, Javier
    [J]. MEDICINA CLINICA, 2012, 139 (13): : 572 - 578
12345